DHUNE

CHU La Timone

Département de Pharmacologie Clinique

264 Rue Saint-Pierre  
13385 Marseille Cedex 5
FRANCE
 

 

Mail :

dhune-contact@univ-amu.fr 

 

Direction :

Pr Olivier BLIN

Directeur du Centre de Pharmacologie Clinique et de Pharmacovigilance 

 

Chargée de mission :

Lisa OTTEN

 

 

    

DHUNE, Centre d’excellence pour les Maladies Neurodégénératives
DHUNE, Centre d’excellence pour les Maladies Neurodégénératives

Industrial exploitation & Dissemination

DHUNE has the full support of 7 local industrial partners (ICDD, Neuroservice, Neuron experts, Phénotype Expertise, Provetech, Vect-Horus) as well as large pharmaceutical companies (Ipsen, Sanofi) who have formally agreed to join the initiative and take part in the Dhune governance.

 

Moreover, DHUNE  has established strong links with most of the companies involved in neurodegenerative diseases in the biomedical (Medtronic, Boston Scientific, Siemens, GE) and pharmaceutical sectors (Roche, Novartis, GSK, Servier, Teva, Astra Zeneca, Lundbeck, J & J, Boehringer Ingelheim, Eli Lilly).

 

This long-term collaboration with industrial partners favours technology transfer, revisions and improvements in the training programs, the launch of new clinical trials and the acceleration in marketing of the latest technology.

 

DHUNE also aims at developing new computerised tools (web interface, mobile applications) for the diagnosis, care and treatment of neurodegenerative diseases.